HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Makoto Nishida Selected Research

Ligation

10/2019Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction.
1/2013Establishment of a novel murine model of ischemic cardiomyopathy with multiple diffuse coronary lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Makoto Nishida Research Topics

Disease

17Atherosclerosis
10/2019 - 11/2002
10Inflammation (Inflammations)
10/2019 - 09/2007
10Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2016 - 12/2006
9Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 06/2007
8Hypertriglyceridemia
02/2022 - 05/2009
8Coronary Artery Disease (Coronary Atherosclerosis)
12/2017 - 02/2003
7Hyperlipidemias (Hyperlipidemia)
09/2012 - 04/2008
6Fibrosis (Cirrhosis)
01/2022 - 09/2007
5Cardiomyopathies (Cardiomyopathy)
01/2022 - 01/2013
5Obesity
08/2012 - 05/2002
4Proteinuria
01/2021 - 03/2012
4Dyslipidemias (Dyslipidemia)
06/2018 - 05/2009
4Neoplasms (Cancer)
06/2016 - 06/2007
3Myocardial Infarction
02/2022 - 01/2013
3Heart Failure
01/2021 - 01/2013
3Tangier Disease
10/2018 - 06/2007
3Hypertension (High Blood Pressure)
10/2013 - 09/2007
3Platelet Glycoprotein IV Deficiency
01/2012 - 05/2009
3Coronary Disease (Coronary Heart Disease)
09/2011 - 12/2009
2Hypertrophy
01/2022 - 09/2007
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
07/2021 - 01/2012
2Cardiomegaly (Heart Hypertrophy)
01/2020 - 01/2019
2Cholesteryl Ester Transfer Protein Deficiency
03/2019 - 01/2018
2Type 2 Diabetes Mellitus (MODY)
06/2018 - 09/2007
2Hyperglycemia
06/2018 - 05/2009
2Body Weight (Weight, Body)
02/2018 - 06/2007
2Insulin Resistance
12/2012 - 06/2007
2Xanthomatosis (Xanthoma)
09/2010 - 08/2005
2Hypoadiponectinemia
10/2007 - 10/2002
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2022
1Fatty Liver
01/2022
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2020
1Lymphoma (Lymphomas)
11/2020
1Hypoxia (Hypoxemia)
10/2019
1Coronary Occlusion
10/2019
1Acute-Phase Reaction
03/2019
1Vitiligo
01/2019

Drug/Important Bio-Agent (IBA)

16AdiponectinIBA
09/2016 - 05/2002
10CholesterolIBA
01/2022 - 08/2005
10HDL LipoproteinsIBA
03/2019 - 08/2005
10Lipoproteins (Lipoprotein)IBA
06/2018 - 05/2009
9Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2007
7HDL CholesterolIBA
03/2019 - 06/2007
7Apolipoprotein B-48IBA
01/2014 - 01/2011
7oxidized low density lipoproteinIBA
01/2014 - 12/2009
6Triglycerides (Triacylglycerol)IBA
02/2018 - 06/2007
4(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA
02/2022 - 02/2018
4Biomarkers (Surrogate Marker)IBA
01/2021 - 07/2011
4CytokinesIBA
01/2018 - 10/2007
4Interleukin-6 (Interleukin 6)IBA
02/2015 - 09/2007
4Apolipoprotein A-I (Apolipoprotein A1)IBA
10/2008 - 08/2005
3Glucose (Dextrose)FDA LinkGeneric
01/2019 - 05/2002
3Hormones (Hormone)IBA
09/2016 - 05/2002
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2015 - 06/2002
3Chylomicron RemnantsIBA
01/2014 - 05/2009
3ApolipoproteinsIBA
01/2014 - 11/2002
3ChylomicronsIBA
01/2014 - 09/2011
3LDL CholesterolIBA
09/2010 - 06/2007
3C-Reactive ProteinIBA
10/2007 - 02/2003
2Probucol (Lorelco)FDA Link
07/2021 - 01/2012
2Complement System Proteins (Complement)IBA
01/2020 - 03/2019
2ProgranulinsIBA
01/2020 - 10/2013
2Cholesterol Ester Transfer ProteinsIBA
03/2019 - 01/2018
2LipidsIBA
03/2019 - 11/2005
2Adenosine Triphosphate (ATP)IBA
01/2019 - 09/2010
2Fenofibrate (CiL)FDA LinkGeneric
02/2018 - 06/2010
2InterleukinsIBA
01/2018 - 09/2015
2fibroblast growth factor 21IBA
01/2018 - 09/2015
2ChemokinesIBA
02/2015 - 03/2013
2ORALIT (ORS)IBA
10/2013 - 07/2011
2Testosterone (Sustanon)FDA Link
10/2013 - 01/2012
2LDL Lipoproteins (beta Lipoproteins)IBA
09/2010 - 06/2007
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2010 - 05/2010
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
09/2010 - 06/2009
2Ezetimibe (Zetia)FDA Link
09/2010 - 09/2010
2TetraspaninsIBA
01/2009 - 07/2008
1Inosine Triphosphate (ITP)IBA
02/2022
1SteroidsIBA
02/2022
1InflammasomesIBA
01/2022
1Pharmaceutical PreparationsIBA
07/2021
17-ketocholesterolIBA
01/2020
1CateninsIBA
01/2020
1Proteinase-Activated ReceptorsIBA
10/2019
1RivaroxabanIBA
10/2019
1CoagulantsIBA
10/2019
1Peptide Hydrolases (Proteases)FDA Link
03/2019
1ProteomeIBA
03/2019
1Apolipoprotein C-IIIIBA
03/2019
1AutoantibodiesIBA
01/2019
1rhododendrolIBA
01/2019
1Sitagliptin Phosphate (Januvia)FDA Link
06/2018
1Dipeptidyl-Peptidase IV InhibitorsIBA
06/2018
1ProstaglandinsIBA
12/2017
1high density lipoprotein receptorsIBA
12/2017

Therapy/Procedure

3Therapeutics
02/2022 - 09/2010
2Ligation
10/2019 - 01/2013
2Drug Therapy (Chemotherapy)
06/2016 - 09/2010
1Organ Transplantation
11/2020
1Kidney Transplantation
11/2020
1Glycemic Control
06/2018